Literature DB >> 23758233

Racemic adrenaline and inhalation strategies in acute bronchiolitis.

Håvard Ove Skjerven1, Jon Olav Gjengstø Hunderi, Sabine Kristin Brügmann-Pieper, Anne Charlotte Brun, Hanne Engen, Leif Eskedal, Marius Haavaldsen, Bente Kvenshagen, Jon Lunde, Leif Bjarte Rolfsjord, Christian Siva, Truls Vikin, Petter Mowinckel, Kai-Håkon Carlsen, Karin C Lødrup Carlsen.   

Abstract

BACKGROUND: Acute bronchiolitis in infants frequently results in hospitalization, but there is no established consensus on inhalation therapy--either the type of medication or the frequency of administration--that may be of value. We aimed to assess the effectiveness of inhaled racemic adrenaline as compared with inhaled saline and the strategy for frequency of inhalation (on demand vs. fixed schedule) in infants hospitalized with acute bronchiolitis.
METHODS: In this eight-center, randomized, double-blind trial with a 2-by-2 factorial design, we compared inhaled racemic adrenaline with inhaled saline and on-demand inhalation with fixed-schedule inhalation (up to every 2 hours) in infants (<12 months of age) with moderate-to-severe acute bronchiolitis. An overall clinical score of 4 or higher (on a scale of 0 to 10, with higher scores indicating more severe illness) was required for study inclusion. Any use of oxygen therapy, nasogastric-tube feeding, or ventilatory support was recorded. The primary outcome was the length of the hospital stay, with analyses conducted according to the intention-to-treat principle.
RESULTS: The mean age of the 404 infants included in the study was 4.2 months, and 59.4% were boys. Length of stay, use of oxygen supplementation, nasogastric-tube feeding, ventilatory support, and relative improvement in the clinical score from baseline (preinhalation) were similar in the infants treated with inhaled racemic adrenaline and those treated with inhaled saline (P>0.1 for all comparisons). On-demand inhalation, as compared with fixed-schedule inhalation, was associated with a significantly shorter estimated mean length of stay--47.6 hours (95% confidence interval [CI], 30.6 to 64.6) versus 61.3 hours (95% CI, 45.4 to 77.2; P=0.01) - as well as less use of oxygen supplementation (in 38.3% of infants vs. 48.7%, P=0.04), less use of ventilatory support (in 4.0% vs. 10.8%, P=0.01), and fewer inhalation treatments (12.0 vs. 17.0, P<0.001).
CONCLUSIONS: In the treatment of acute bronchiolitis in infants, inhaled racemic adrenaline is not more effective than inhaled saline. However, the strategy of inhalation on demand appears to be superior to that of inhalation on a fixed schedule. (Funded by Medicines for Children; ClinicalTrials.gov number, NCT00817466; EudraCT number, 2009-012667-34.).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758233     DOI: 10.1056/NEJMoa1301839

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

1. 

Authors:  Teeranai Sakulchit; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-12       Impact factor: 3.275

Review 2.  Hypertonic Saline for the Treatment of Bronchiolitis in Infants and Young Children: A Critical Review of the Literature.

Authors:  Jeffrey Baron; Gladys El-Chaar
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

3.  Nebulized epinephrine for young children with bronchiolitis.

Authors:  Teeranai Sakulchit; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-12       Impact factor: 3.275

Review 4.  Recent evidence on the management of bronchiolitis.

Authors:  Alan R Schroeder; Jonathan M Mansbach
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

5.  Overtesting and overtreatment-statement from the European Academy of Paediatrics (EAP).

Authors:  Ketil Størdal; Corinne Wyder; Andreas Trobisch; Zachi Grossman; Adamos Hadjipanayis
Journal:  Eur J Pediatr       Date:  2019-09-10       Impact factor: 3.183

6.  Skin Barrier Function and Staphylococcus aureus Colonization in Vestibulum Nasi and Fauces in Healthy Infants and Infants with Eczema: A Population-Based Cohort Study.

Authors:  Teresa Løvold Berents; Karin Cecilie Lødrup Carlsen; Petter Mowinckel; Håvard Ove Skjerven; Bente Kvenshagen; Leif Bjarte Rolfsjord; Maria Bradley; Agne Lieden; Kai-Håkon Carlsen; Peter Gaustad; Petter Gjersvik
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

Review 7.  Recent advances in the management of acute bronchiolitis.

Authors:  Claudia Ravaglia; Venerino Poletti
Journal:  F1000Prime Rep       Date:  2014-11-04

8.  Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants.

Authors:  Eugenio Baraldi; Marcello Lanari; Paolo Manzoni; Giovanni A Rossi; Silvia Vandini; Alessandro Rimini; Costantino Romagnoli; Pierluigi Colonna; Andrea Biondi; Paolo Biban; Giampietro Chiamenti; Roberto Bernardini; Marina Picca; Marco Cappa; Giuseppe Magazzù; Carlo Catassi; Antonio Francesco Urbino; Luigi Memo; Gianpaolo Donzelli; Carlo Minetti; Francesco Paravati; Giuseppe Di Mauro; Filippo Festini; Susanna Esposito; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2014-10-24       Impact factor: 2.638

9.  Treatment for acute bronchiolitis before and after implementation of new national guidelines: a retrospective observational study from primary and secondary care in Oslo, Norway.

Authors:  Nicolai Klem; Håvard Ove Skjerven; Beate Nilsen; Mette Brekke; Odd Martin Vallersnes
Journal:  BMJ Paediatr Open       Date:  2021-05-20

Review 10.  Acute bronchiolitis in infants, a review.

Authors:  Knut Øymar; Håvard Ove Skjerven; Ingvild Bruun Mikalsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-04-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.